Skip to main content

Clinical Influencer

Dr Ricky Frazer MBBCH (Hons), MSc (MedEduc), BSc, PgCert (Onc), PgCert (ClinLead), PgCert (AcuteMed) MAcadMEd, MRCP, AFFMLM

Ricky Frazer is a Medical Oncology Consultant working at Velindre Cancer Centre (VCC) in Cardiff. He specialises in renal cancer, skin cancer and acute oncology and is clinical lead for the Acute Oncology Assessment Unit at VCC and the Immunotherapy Toxicity Management Service. He is one of the founding members of the UK Renal Oncology Collaborative (UK ROC). He has recently completed and was awarded a distinction in the postgraduate certificate in Acute Medicine at the University of South Wales. He was a Welsh Clinical Leadership Training Fellow with the Wales Deanery and is a Founding Associate Fellow of the Faculty of Medical Leadership and Management. He has a strong educational interest and is currently a Royal College of Physicians (RCP) College Tutor and Faculty Lead. He is also an Honorary Lecturer at Cardiff University. He has completed a Master’s in Medical Education and was awarded the National Munro Medal by the RCP for excellence and leadership in education. He is Vice President of the National Immuno-Oncology Clinical Network (IOCN) and Co-leads the monthly National Immuno-Oncology Education Forum. He has been heavily involved in the inception and development of the national Practical Management of your Immuno-Oncology Patient (PMI-OP) educational series exploring immunotherapy identification and management with specialist colleagues. In 2023 he was awarded the individual leader of the year for Velindre NHS Trust and the South East Wales Immunotherapy Toxicity Team won the award for education, research and innovation and improving patient experience. The immunotherapy team were also awarded the coveted Macmillan UK National Innovation Excellence Award in Glasgow in November 2023. He is a Voluntary Clinical Advisor for Macmillan. He is co-founder of a Podcast called ‘The Immunobuddies’ launched in February 2023 which covers the use and management of immunotherapy in treating cancer. The podcast is freely available on a number of online platforms including Apple, Amazon and Spotify and has been downloaded in 93 countries worldwide.